Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Shionogi & Co. Ltd.](/topic/$4507t)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$4507t/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$4507t/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +9%  
**1 Month**: XX% -X%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-01-24  

**Most Supportive Themes**
- **AI in Drug Development:** (60%) Social posts highlight the positive impact of AI in drug development, improving efficiency and reducing clinical trial times.
- **PrEP for COVID-19:** (30%) The social community is responding positively to Shionogi's developments in preventative measures for respiratory diseases, specifically for COVID-19.
  
**Most Critical Themes**
- **Clinical Trial Concerns:** (0%)  Social posts express concerns about clinical trial methodologies.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | XXX      | XX% | XXX     | XX% | XX       | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
| TikTok  | XX       | X%  | XXX     | XX% | X        | X% |
| X       | XX       | X%  | X       | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Shionogi & Co. Ltd.

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +9%
1 Month: XX% -X%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-01-24

Most Supportive Themes

  • AI in Drug Development: (60%) Social posts highlight the positive impact of AI in drug development, improving efficiency and reducing clinical trial times.
  • PrEP for COVID-19: (30%) The social community is responding positively to Shionogi's developments in preventative measures for respiratory diseases, specifically for COVID-19.

Most Critical Themes

  • Clinical Trial Concerns: (0%) Social posts express concerns about clinical trial methodologies.

Network engagement breakdown:

Network Positive % Neutral % Negative %
Reddit XXX XX% XXX XX% XX X%
News X X% X X% X X%
TikTok XX X% XXX XX% X X%
X XX X% X X% X X%
YouTube X X% X X% X X%
Total XXX XX% XXX XX% XX X%
Shionogi & Co. Ltd. Sentiment
/topic/$4507t/sentiment